EUVIMEDEUVIMED entdecken
Crossref

Liquid Metal Nanoparticles‐Mediated Mitochondrial Damage Enhances Immunogenic Cell Death for Cancer Vaccine Therapy

Yuxia Qi, Zhongyang Yu, Jie Zhang, Chi Zhang, Xiaoshuai Wang, Fan Yang, Yunlong Bai, Jun-Xiao Yuan, Minghui Guo, Dawei Wang, Kaiwen Hu, Tian Zhou und 2 weitere

Advanced Materials · 2026-02 · 38 (11)

DOI: 10.1002/adma.202520580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 04.01.2026. Verfasst von Yuxia Qi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Metal Nanoparticles, Mitochondria, Cancer Vaccines. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer vaccines face limitations due to the immunosuppressive tumor microenvironment (TME) and the low immunogenicity of tumor antigens. Immunogenic cell death (ICD), triggered by mitochondrial dysfunction, provides a promising strategy to enhance tumor antigen release and immune activation. However, actively amplifying mitochondrial damage‐induced ICD remains challenging. In this study, we developed a vaccine in which liquid metal nanoparticles (LMPs) target tumor cells, undergo self‐assembly and aggregation on the cell surface to achieve efficient uptake, fuse intracellularly to prolong retention, and release Ga 3+ ions through an iron‐substitution pathway to induce mitochondrial damage, thereby triggering ICD. In combination with irreversible electroporation (IRE), this approach mediates durable tumor‐specific immunotherapy. Specifically, LMPs target tumor cell integrin αvβ6 to initiate self‐assembly and aggregation, leading to efficient cellular internalization. Within the acidic lysosomal environment, LMPs undergo fusion and partially escape into the cytosol, enabling prolonged intracellular retention and sustained release of Ga 3+ ions. The released Ga 3+ disrupts mitochondrial structure and inhibits electron transport via iron substitution, resulting in pronounced mitochondrial damage. Synergistic IRE and LMPs increase the liberation of mitochondrial damage‐associated DAMPs and tumor antigens, driving robust ICD and long‐term systemic antitumor immunity. This dual‐modality strategy provides a blueprint for nanomaterial‐enabled amplification of ICD in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunogenic Cell DeathMetal NanoparticlesMitochondriaCancer VaccinesAnimalsHumansMiceCell Line, TumorGalliumImmunotherapyTumor MicroenvironmentNeoplasms

Stichwörter der Autor:innen

cancer nanovaccineimmunotherapyirreversible electroporationliquid metal nanoparticlesself‐fusion

Substanzen

Cancer VaccinesGallium

Autor:innen und Institutionen

  • Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.
  • School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
  • State Key Laboratory of Cryogenic Science and Technology and Beijing Key Laboratory Cryobiomedicine, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, China.
  • School of Future Technology, University of Chinese Academy of Sciences, Beijing, China.
  • Geriatrics Department, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
  • National Center for Nanoscience and Technology (NCNST), Beijing, China.

ORCID-Profile: Wei Rao

Förderung

  • Strategic Priority Research Program of the Chinese Academy of Sciences
  • National Natural Science Foundation of China

Zitieren

APA

Qi, Y., Yu, Z., Zhang, J., Zhang, C., Wang, X., Yang, F., Bai, Y., Yuan, J. X., Guo, M., Wang, D., Hu, K., Zhou, T., Wang, L., & Rao, W. (2026). Liquid Metal Nanoparticles‐Mediated Mitochondrial Damage Enhances Immunogenic Cell Death for Cancer Vaccine Therapy. Advanced Materials, 38(11). https://doi.org/10.1002/adma.202520580

Vancouver

Qi Y, Yu Z, Zhang J, Zhang C, Wang X, Yang F, et al. Liquid Metal Nanoparticles‐Mediated Mitochondrial Damage Enhances Immunogenic Cell Death for Cancer Vaccine Therapy. Advanced Materials. 2026;38(11). doi:10.1002/adma.202520580

BibTeX
@article{Qi2026,
  author = {Qi, Yuxia and Yu, Zhongyang and Zhang, Jie and Zhang, Chi and Wang, Xiaoshuai and Yang, Fan and Bai, Yunlong and Yuan, Jun-Xiao and Guo, Minghui and Wang, Dawei and Hu, Kaiwen and Zhou, Tian and Wang, Lei and Rao, Wei},
  title = {Liquid Metal Nanoparticles‐Mediated Mitochondrial Damage Enhances Immunogenic Cell Death for Cancer Vaccine Therapy},
  journal = {Advanced Materials},
  year = {2026},
  volume = {38},
  number = {11},
  doi = {10.1002/adma.202520580}
}
Kostenlos starten →